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We present a case of Warthin-like papillary thyroid carcinoma in a 22-year-old woman and a review of the literature on the topic.
The patient had the occasional discovery of a hypoechoic thyroid nodule of approximately 18mm, characterized by irregular
margins, hyperechoic spots, rich intra- and perilesional vascularization, and a suspicious enlarged right laterocervical lymph
node. Fine-needle aspiration was performed for both lesions and the diagnosis of papillary thyroid carcinoma without lymph
node involvement was made. The patient underwent thyroidectomy and central neck lymphadenectomy without complications.
Histopathological examination suggested a Warthin-like papillary carcinoma of the thyroid gland, with all the removed lymph
nodes being free of disease. The patient subsequently underwent iodine ablative therapy and she remains free of disease one
year after surgery. Warthin-like papillary thyroid carcinoma is a recently described variant of papillary thyroid cancer that is
frequently associated with lymphocytic thyroiditis. Morphologically, it resembles Warthin tumors of the salivary glands, with T
and B lymphocytes infiltrating the stalks of papillae lined with oncocytic cells. Surgical and postoperative management is identical
to that of classic diﬀerentiated thyroid cancer, while prognosis seems to be favourable.
1. Introduction
We present a case of a Warthin-like papillary thyroid tumor
(WaLPTT) in a 22-year-old woman with a family history of
thyroid goitre. WaLPTT is a rare variant of papillary thyroid
carcinoma (PTC) with approximately 80 cases reported in
literature to date [1]. It was first described in 1995 by Apel
et al., who noticed in their series of 13 cases morphological
resemblance to Warthin’s tumour of the salivary glands [2].
Through our case we describe the clinical and diagnostic
features and surgical and oncologic management of patients
with WaLPTT and present a review of the literature.
2. Case Presentation
In December 2010, a 22-year-old woman underwent an
ultrasound (US) examination of the thyroid as a practical
demonstration in the medical school of the local university
where she studiesmedicine. The examination showed a gland
that was normal in size with a heterogeneous parenchymal
echostructure. In the inferior pole of the right lobe, a
hypoechoic nodule of approximately 18mm in greatest
diameter was detected. It was characterized by irregular
margins, hyperechoic spots and rich intra- and perilesional
vascularization. Several enlarged lymph nodes were also
found bilaterally in the laterocervical regions, but only one
node on the right side was suspicious for metastasis on
contrast US.
The patient had a family history of thyroid goitre, but no
previous exposure of the neck to radiation or other risk fac-
tors for thyroid cancer. Physical examination did not reveal
any significant alteration of the thyroid gland. No cervical
lymph node swelling was detected by palpation, despite the
ultrasonographic findings. Routine laboratory tests revealed
slight hypothyroidism (FT4: 0.66 ng/dL, range 0.77–2.19)
and a raised anti-TPO antibody level (519.0UI/mL, range
0.00–10.00), suggesting chronic autoimmune thyroiditis.
A computed tomography (CT) scan of the neck and
mediastinum confirmed the presence of several lymph
nodes of approximately 10mm in size bilaterally in
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Figure 1: Hematoxilin and Eosin, stained sections of the tumor.
the laterocervical and submandibular regions, most of which
were oval in shape. No lymph node enlargement in the
mediastinum or pulmonary or bone metastatic lesions was
observed.
Fine-needle aspiration (FNA) showed numerous multi-
nucleated and micropapillary cell groups, with voluminous
nuclei and often with pseudoinclusions and a small number
of lymphocytes. The diagnosis was PTC. Neoplastic involve-
ment of the suspicious right laterocervical lymph node was
excluded through FNA.
The patient underwent total thyroidectomy on March
2011. Central neck lymphadenectomy was performed, as
at least two swollen nodes were detected in that area. The
nodes were sent for frozen section pathological examination,
which showed the absence of tumoral invasion. Pathological
analysis of the specimen confirmed the presence of an
18mm moderately diﬀerentiated papillary carcinoma with
abundant Warthin-like lymphoid infiltration and capsular
invasion. Furthermore, the gland was aﬀected by chronic
lymphocytic thyroiditis (Figure 1). Immunohistochemistry
was not performed as the morphological picture was clear.
There were no postoperative complications and the
patient was discharged on the second postoperative day.
She underwent I131 radio-ablative therapy (106mCi), as
scintigraphy performed three months after surgery showed
residual areas of activity in the neck, while her plasmatic
thyroglobulin level was 12.5 ng/mL. One year after surgery,
the blood thyroglobulin level was almost undetectable and
the patient was stable and disease-free.
3. Discussion
The Warthin-like variant of papillary thyroid carcinoma was
first described in 1995 by Apel et al. [2] and represents a
rare variant of PTC, with approximately eighty cases having
been reported in literature to date [1]. Apel et al. chose
the name “Warthin-like tumor” because of its histological
resemblance to papillary cystoadenoma lymphomatosum or
Warthin tumor of the salivary glands.
Patients aﬀected by WaLPTT have similar demographic
and clinical characteristics to those aﬀected by PTC. Table 1
shows these characteristics, as reported in the most consis-
tent series published to date, excluding case reports [2–7].
WaLPTT typically arises at an earlier age, as compared to
PTC, and there is also a stronger predominance of females.
Among the 54 patients reviewed, the mean age was 50
years and there were only five males (9%). The clinical
presentation is the same as that for other diﬀerentiated
thyroid tumors: absence of signs and symptoms when the
lesions are single, small, and deep; palpable masses, glandular
swelling, and swallowing and/or phonatory alterations for
larger, superficial, and/or multiple lesions. Signs, symptoms,
and alterations in thyroid function related to thyroiditis or
goitre may be also present. Furthermore, features of US and
CT imaging of WaLPTT are identical to those for PTC. As
a consequence, diagnosis of WaLPTT cannot be based on
clinical and imaging data alone.
FNA may be useful in this regard, but its role in the
diagnosis of WaLPTT is not yet clear. Generally, it is possible
to appreciate the presence of groups of follicular cells and
papillary fragments against a background of lymphocytes
and plasma cells, which infiltrate the fibrovascular cores.
Oncocytic cells are often admixed with lymphocytes. The
nuclear characteristics of tumoral cells are generally those
of PTC (nuclear chromatin clearing, membrane thickening,
grooves, and pseudoinclusions) and oncocytes (round nuclei
with coarse chromatin and prominent nucleoli) [5]. Such
patterns suggest PTC or lymphocytic thyroiditis, or both.
Indeed, these were the most frequent diagnoses in the
literature on patients aﬀected byWaLPTT. Baloch and LiVolsi
report data on seven FNAs; there were four diagnoses of
PTC, two of lymphocytic thyroiditis and one of atypical
cells [5]. In the series of D’Antonio et al., all patients
underwent FNA and two of them had a diagnosis of PTC;
in one case, the results of FNA were inconclusive [4]. In
our case and those of Amico et al., Sarkady et al., and
Lam et al., the preoperative diagnosis based on FNA was
PTC or thyroiditis [1, 8, 9]. FNA is probably more useful for
the evaluation of cervical lymph node involvement, as in our
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Table 1: Demographic and clinical data of patients with WaLPTT as depicted in the literature.
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case, and for planning the appropriate surgical strategy and
multidisciplinary management.
The macroscopic appearance of WaLPTT is generally
that of a white-greyish, well circumscribed nodule, unen-
capsulated and confined to the thyroid gland. It may contain
cystic and/or haemorrhagic areas. Its mean size among the
54 reviewed patients was 1.5 cm (range 0.3 to 5 cm). To
our knowledge, only one paper has reported a WaLPTT
larger then 5 cm [1]. The color of the remaining thyroid
parenchyma generally ranges from red brownish to tan and a
variable number of nodules of diﬀerent sizes may be present.
The histological diagnosis of WaLPTT is based on the
evidence of a morphological pattern featuring papillae lined
by oncocytic cells admixed with lymphocytes and sparse
plasma cells. The distinctive feature is the lymphocytic infil-
tration of the stalks of the papillae. Furthermore, it is possible
to observe cysts or a small number of tall cells. Vascular
and capsular invasions are rare. Diﬀerential diagnosis must
be conducted with other variants of papillary cancer with
similar morphology, such as Hurthle cell carcinoma (HCC)
and tall cell carcinoma (TCC). The former usually lacks
lymphoplasmacytic infiltrates and is rarely associated with
lymphocytic thyroiditis [2, 5]; the latter is characterized
by a papillary structure with elongated oncocytes, with a
height that is more than twice their width, and by neoplastic
aggressiveness with more frequent vascular, capsular, and
nodal invasion [10].
The role of immunohistochemistry in diﬀerential diag-
nosis with Hurthle cell and tall cell carcinomas is limited.
Indeed, in our case it was not necessary for diagnosis as
the morphological pattern was clear. Intense staining for the
following markers has been reported in literature: galectin-3,
HBME-1, CK19, TTF-1, thyroglobulin, EMA, AE1/AE3,
S-100 protein, cyclin D1 and UCHL1, CD3+, CD20+,
and CD79+ (for the lymphocytic population). Ostrowski
and Merino believe that CD15 immunostaining represents
a distinctive characteristic of tall cell carcinomas and a
predictive factor for advanced stage or poor prognosis [11].
Nevertheless, this marker was also found in WaLPTT, which
has a better prognosis than TCC.
The neoplastic behaviour of WaLPTT seems to be similar
or even better than that of classical PTC. Vera-Sempere et al.
hypothesized that it is a hybrid of TCC and HCC and
some immunohistochemical evidence supports this theory
[12]. Short- and long-term prognosis seems to be excellent.
Lam et al. describe a case of a 74-year-old Chinese woman
aﬀected by WaLPTT with dediﬀerentiated (anaplastic) area
[9]. She had a 3.5 cm PTC of the right lobe with ipsilateral
recurrent laryngeal nerve involvement; a supraclavicular
lymph node was shown by FNA to be metastatic. The patient
refused any treatment for three years, but agreed to undergo
surgery when her condition worsened. She underwent pal-
liative surgery and died 15 months later. This case seems to
have involved the natural evolution of an advanced anaplastic
thyroid carcinoma (with areas of WaLPTT) that remained
untreated for a long time, rather than a typical WaLPTT.
Elsewhere, Amico et al. reported a case of a 6 cm WaLPTT
with less than 5% of the tumor area being occupied by
anaplastic tissue in a 79-year-old woman with laterocervical
lymph node metastasis [1]. The patient promptly underwent
surgery and was alive without evidence of disease 23 months
later. It is probable that in such situations the anaplastic
component, even when it represents a small percentage of
the overall tumor area, dictates the prognosis, which may be
poor when appropriate treatment is not provided.
Other cases of cervical nodal metastasis have been
reported in literature, but such events are generally rare
[3, 8]. Among the 54 cases reviewed here, only 12 (22%) had
lymph node metastasis, which represents an incidence lower
than that for traditional PTC. Prognosis was favourable in
almost all cases, but follow-up times were generally short,
with only a few cases being followed for more than 3 years.
The most reliable explanation for the low rates of nodal
involvement and favourable prognosis in WaLPTT is the
presence of lymphatic tissue within the tumor, which seems
to contrast and restrain neoplastic progression and diﬀusion.
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The therapeutic management of patients with WaLPTT
is similar to that of patients with PTC and depends
substantially on the disease stage and the presence of neg-
ative prognostic factors such as familiarity, history of neck
irradiation, and syndromic endocrine disease. The diagnosis
of WaLPTT is histopathological and generally based on
surgical specimens. This means that the therapeutic plan
for patients with WaLPTT must be assessed after surgery.
The reports reviewed in this paper are mostly pathological
and lack detailed data on postoperative treatments such as
radioiodine ablation and follow-up modalities. As the bio-
logical behaviour of WaLPTT is comparable to that of PTC,
postoperative management should also be identical. Further
surgery for completion of thyroidectomy or lymphadenec-
tomy, radioiodine ablation, and other treatments may be
employed in high-risk patients. Our patient underwent
postoperative radioiodine therapy due to evidence of residual
thyroid tissue and capsular invasion and is undergoing the
same postoperative follow-up and treatment program used
in patients with classic PTC.
4. Conclusions
Warthin-like papillary thyroid carcinoma is a recently
described variant of papillary thyroid cancer that is fre-
quently associated with lymphocytic thyroiditis. Morpholog-
ically, it resembles Warthin tumors of the salivary glands,
with T and B lymphocytes infiltrating the stalks of papillae
lined with oncocytic cells. Diagnosis is histopathological and
based on morphology rather than immunohistochemistry.
Surgical and postoperative management is identical to that
of classic diﬀerentiated thyroid cancer, while prognosis seems
to be favourable. Larger prospective long-term studies are
necessary to better understand the biological behaviour of
such tumors and their clinical and prognostic impact.
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